Dash Equity Research Note
Macro Catalysts 13F My reports Glossary
◉ English
English
Coming soon
Español
Türkçe
한국어
日本語
Menu
Macro Catalysts 13F My reports Glossary
Analyze a stock
In this report
GRABWait$4.07+17%NXDRNot a candidate$2.80+17%
Each name is analysed on its own. Dash does not size positions or build baskets.
GRAB High Growth
Grab Holdings Limited / Technology / $14.24B market value
Price today
$3.48
A good business at a discount, but the stock is falling. The committee says wait.
Grab Holdings Limited appears about 17% undervalued based on our multi-framework valuation. Earnings quality is rated B, solid with decent cash flow backing. 2 out of 7 investment frameworks support buying, with potential upside of +120% in a best-case scenario. The main risk to watch: the stock is below its long-term trend line.
What we think it's worth
$4.07
+17% above today's price
Trend strength
0/100
Weak and falling

The investment decision

1 Buy4 Hold2 Wait
Greenwald
Value
Hold
56 / 100
Druckenmiller
Momentum
Wait
26 / 100
Laffont
Growth
Hold
70 / 100
Ackman
Catalyst
Buy
77 / 100
Dalio
Macro
Hold
50 / 100
Griffin
Risk
Hold
57 / 100
Cohen
Vs. peers
Wait
36 / 100
What to doWait
Fundamentals look constructive, but the chart is weak. Wait for trend confirmation, a move back above the 200-day average, before entering. Waiting costs you about 17% of headroom; being early into a falling stock has cost far more.
• What would change this: the price closing back above its 200-day average of $4.14, which would move the trend score off 0. If that happens and the value case is still in place, this becomes a buy.

Where the price sits

6 independent answers to "what is this worth", on one scale.
$1.46Floor price
$5.86Wall Street
$3.48Today
$4.07Our value
See the full analysis ↓
Same page, keep scrolling. Valuation, the business, the risks, and what each investor said.
GRAB full analysis What it's worth The business What could go wrong The committee
01

What it's worth

Every method, one scale, $0 to $8

Grab Holdings Limited looks 17% undervalued with B-grade earnings.

6 ways of valuing Grab Holdings land between $1.34 and $5.86. Our number, $4.07, comes from Growth-adjusted earnings, the right primary method for a company of this profile.
Our fair valueGrowth-adjusted earnings, primary
$4.07+17% vs price
Wall Street consensusAverage analyst target
$5.86+68%
Peers, cash profitshow similar companies are priced
$1.34-62%
Peers, free cash flowcash left after running the business
$4.19+20%
Peers, revenuepriced on sales, not profit
$3.45-1%
Floor priceWorth of today's profits if growth stopped
$1.46-58%
$0$2$4$6$8
How to read this. Each bar runs from that method's answer to today's price, so the length of the bar is the disagreement. The floor price is not a target and not a prediction of a crash: it is what Grab Holdings would be worth if it stopped growing tomorrow. The gap between the floor and today's price, 58% of what you pay, is the growth you are paying for, and it is the part that disappears fastest if growth slows.
02

The business

What the quality readings say
On quality, Grab Holdings reads strongest through the catalyst lens at 77 out of 100. This is the half of the report that says judge the business on its own merits, separately from what the price is doing.
Return on invested capital6.8%
0%How much profit each dollar invested returns30%
Growth plus margin24
0revenue growth + profit margin, above 40 is strong80
Growth score70
0How this lens rates the growth100
Debt load0x×
0×Debt vs equity, low is safer2×
Volatility vs the market0.89×
0×moves 11% less than the market2×
B
Earnings quality
Reported profit is backed by real cash. Not perfect, not a concern.
What has to go right. Wall Street's $5.86 assumes the current growth rate keeps compounding. Every dollar of the 58% of the price that sits above the floor rests on that continuing. Nothing in the readings above says it will not; they say whether the company is capable of it.
03

What could go wrong

The case against buying today
The risk here is the multiple, not the balance sheet. Most of what you pay is growth that has not happened yet, and that is the part a re-rating takes first.
Downside caseVolatility-based
$1.91-45.0%
TodayMarket price
$3.48 
Our valuePrimary method
$4.07+17.0%
Same $0 to $8 scale as section 01
Read the asymmetry. You are risking a 45% drawdown in a bad tape to earn +17% of headroom to our value. That ratio, not the quality of the company, is what the call above is about.
Ranked risks
The trend is against youTrend strength reads 0 out of 100. Price is under its key moving averages, and the momentum lens is the one that will not buy weakness.
You are paying for growth58% of today's price is the value of growth that has not happened yet. A slowdown removes that part first.
Balance sheet is not the problemDebt to equity of 0xx. Solvency is not a live risk in any scenario here.
04

The committee

1 buy · 4 hold · 2 wait
Seven investing styles, run over the same numbers. They are meant to disagree, and where they disagree is where the decision lives.
AckmanCatalyst lens
Buy
There is an identifiable driver here rather than a hope for a re-rating, which is what this lens wants to see.
77
LaffontGrowth lens
Hold
Growth and margin together read 24, respectable but not rare.
70
GriffinRisk lens
Hold
The risk readings are the constraint: debt to equity of 0xx and volatility of 0.89x the market.
57
GreenwaldValue lens
Hold
Quality is not the question, price is. The floor price of $1.46 sits well below today, so this lens will not call it cheap.
56
DalioMacro lens
Hold
Conditions are neutral: mildly supportive, not a reason to act on their own.
50
CohenVs. peers lens
Wait
Against comparable companies the multiples here are rich.
36
DruckenmillerMomentum lens
Wait
The chart disagrees with the story. Price is below its key averages, and this lens does not buy weakness, however good the company is.
26
NXDR Pre-Revenue / Early Stage
NXDR / Communication Services / $926.50M market value
Price today
$2.40
No earnings methods. The floor price and the growth-adjusted earnings method both need positive profits, so neither is shown. The valuation range below runs on the methods that do not depend on earnings.
NXDR does not earn a profit yet, so we cannot value it the way we value the rest.
Without positive profits, the earnings-based methods cannot run at all. What follows is only what the other lenses can see: the trend, the balance sheet, and how the market prices comparable companies. Treat every number on this page as thinner evidence than it would be for a profitable company.
What we think it's worth
$2.80
+17% above today's price
Trend strength
95/100
Strong and rising

The investment decision

2 Buy3 Hold2 Wait
Greenwald
Value
Wait
37 / 100
Druckenmiller
Momentum
Buy
97 / 100
Laffont
Growth
Hold
65 / 100
Ackman
Catalyst
Buy
80 / 100
Dalio
Macro
Hold
50 / 100
Griffin
Risk
Wait
8 / 100
Cohen
Vs. peers
Hold
62 / 100
What to doNot a candidate
No buy language is generated for a company without earnings. Watch for the first profitable quarter, then the full framework applies.
• What would change this: the first quarter of positive operating profit, which is what the earnings-based methods need before they can run at all.

Where the price sits

3 independent answers to "what is this worth", on one scale.
$3.35Wall Street
$2.40Today
$2.80Our value
See the full analysis ↓
Same page, keep scrolling. Valuation, the business, the risks, and what each investor said.
NXDR full analysis What it's worth The business What could go wrong The committee
01

What it's worth

Every method, one scale, $0 to $5

NXDR looks 17% undervalued with C-grade earnings.

3 ways of valuing NXDR land between $2.80 and $4.38, and not one of them is an earnings method, because there are no earnings to work from. Read our number, $2.80, as the middle of a thin range rather than a considered target.
Our fair valueNo earnings methods available
$2.80+17% vs price
Wall Street consensusAverage analyst target
$3.35+40%
Peers, revenuepriced on sales, not profit
$4.38+83%
$0$1$2$4$5
How to read this. Each bar runs from that method's answer to today's price, so the length of the bar is the disagreement. The floor price is not a target and not a prediction of a crash: it is what NXDR would be worth if it stopped growing tomorrow. The gap between the floor and today's price, 96% of what you pay, is the growth you are paying for, and it is the part that disappears fastest if growth slows.
02

The business

What the quality readings say
On quality, NXDR reads strongest through the momentum lens at 97 out of 100. This is the half of the report that says judge the business on its own merits, separately from what the price is doing.
Return on invested capital-7.2%
0%How much profit each dollar invested returns30%
Growth plus margin-46
0revenue growth + profit margin, above 40 is strong80
Growth score65
0How this lens rates the growth100
Debt load0x×
0×Debt vs equity, low is safer2×
Volatility vs the market1.37×
0×moves 37% more than the market2×
C
Earnings quality
Average. Worth watching how profit converts to cash.
What has to go right. Wall Street's $3.35 assumes the current growth rate keeps compounding. Every dollar of the 96% of the price that sits above the floor rests on that continuing. Nothing in the readings above says it will not; they say whether the company is capable of it.
03

What could go wrong

The case against buying today
The risk here is the multiple, not the balance sheet. Most of what you pay is growth that has not happened yet, and that is the part a re-rating takes first.
Downside caseVolatility-based
$1.32-45.0%
TodayMarket price
$2.40 
Our valuePrimary method
$2.80+16.8%
Same $0 to $5 scale as section 01
Read the asymmetry. You are risking a 45% drawdown in a bad tape to earn +17% of headroom to our value. That ratio, not the quality of the company, is what the call above is about.
Ranked risks
You are paying for growth96% of today's price is the value of growth that has not happened yet. A slowdown removes that part first.
There are no profits to valueEvery earnings-based method is unavailable, so the range below is thinner than it would be for a profitable company.
Balance sheet is not the problemDebt to equity of 0xx. Solvency is not a live risk in any scenario here.
04

The committee

2 buy · 3 hold · 2 wait
Seven investing styles, run over the same numbers. They are meant to disagree, and where they disagree is where the decision lives.
DruckenmillerMomentum lens
Buy
The chart confirms the story. Price is above its key averages and the trend is intact.
97
AckmanCatalyst lens
Buy
There is an identifiable driver here rather than a hope for a re-rating, which is what this lens wants to see.
80
LaffontGrowth lens
Hold
Growth and margin together read -46, respectable but not rare.
65
CohenVs. peers lens
Hold
Against comparable companies this prices roughly in line.
62
DalioMacro lens
Hold
Conditions are neutral: mildly supportive, not a reason to act on their own.
50
GreenwaldValue lens
Wait
Quality is not the question, price is. The floor price of $0.09 sits well below today, so this lens will not call it cheap.
37
GriffinRisk lens
Wait
The risk readings are the constraint: debt to equity of 0xx and volatility of 1.37x the market.
8